Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Pharmazeutisch
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Stärke
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Packungsgröße
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Form
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Nebenwirkungen
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.